Key result
An updated and streamlined hospital stroke guideline was associated with a significant reduction in stroke recurrence at 3 months compared to the pre-intervention period.
Why the study?
Stroke recurrence rates remain high after an index event, and evidence-based treatments reduce this risk, prompting evaluation of the effect of an updated hospital stroke guideline on prescribing practices and recurrence.
Does an updated and streamlined hospital stroke guideline reduce stroke recurrence at 3 months in patients with TIA or ischaemic stroke?
Observational (n=396)
No
Does an updated and streamlined hospital stroke guideline reduce stroke recurrence at 3 months in patients with TIA or ischaemic stroke?
Updating and simplifying local clinical stroke guidelines is associated with improved secondary prevention prescribing and a significant reduction in 3-month stroke recurrence.
Answers are grounded in this paper and cite their sources.
May support local stroke guideline simplification for secondary prevention; leaves open need for randomized confirmation.
Background Stroke recurrence rates following an index event remain high compared with the baseline population. Evidence-based stroke treatments reduce this risk. Aims To determine the effect of an updated and streamlined hospital stroke guideline on prescribing practices and stroke recurrence rates at 3 months. Methods Hospital registries were searched for ICD-10 codes for transient ischaemic attack (TIA) and ischaemic stroke between July 2019 and July 2020. Data on patient demographics, discharge documentation, and other outcomes of interest were dichotomised into pre and post-intervention. Results 396 patients were identified. There was a significant reduction in the stroke recurrence rate at 3 months post guideline update (8.3% vs 2.2%, OR 0.24, p<0.01). There were significant improvements in prescriptions for statins (66.5% vs 81.2%, p≤0.01) and antihypertensives (40.7% vs 50.7%, p=0.05), and documentation of lipid and blood pressure targets in discharge letters. There was a trend towards greater use of dual antiplatelet therapy (25.2% vs 34.1%, p=0.057). Conclusion In this audit, we found an association between the guideline update and improved patient outcomes and prescribing practices. We were unable to directly attribute the reduction in stroke recurrence to any single factor. This may be a chance finding and warrants investigation in other settings.
No takes yet. Share an insight, caveat, or question.
Leung et al. (2023) conducted an observational in Transient ischaemic attack (TIA) and ischaemic stroke (n=396). Updated and streamlined hospital stroke guideline vs. Pre-intervention period (prior guidelines) was evaluated on Stroke recurrence at 3 months (OR 0.24, 95% CI 0.07-0.73, p=<0.01). An updated and streamlined hospital stroke guideline was associated with a significant reduction in stroke recurrence at 3 months compared to the pre-intervention period.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: